Related Experiment Video
Updated: Jun 13, 2026
05:56
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Progressive familial intrahepatic cholestasis type 1
Coen C Paulusma1, Ronald P J Oude Elferink, Peter L M Jansen
1Tytgat Institute of Liver and Gastrointestinal Research and Department of Gastroenterology and Liver Disease, Academic Medical Center, Amsterdam, The Netherlands.
Seminars in Liver Disease
|April 28, 2010
Summary
Progressive familial intrahepatic cholestasis type 1 (PFIC1) is a rare genetic liver disease caused by ATP8B1 gene mutations. This deficiency leads to liver and potentially hearing issues due to membrane instability.
Area of Science:
- Hepatology
- Genetics
- Molecular Biology
Background:
- Progressive familial intrahepatic cholestasis type 1 (PFIC1) is a rare, early-onset genetic liver disease.
- Characterized by elevated bile salts, jaundice, and pruritus, often with normal or low gamma-glutamyltransferase.
- Caused by mutations in the ATP8B1 gene, affecting hepatocyte canalicular membrane function.
Purpose of the Study:
- To investigate the molecular mechanisms underlying cholestasis in ATP8B1 deficiency.
- To explore the role of ATP8B1 protein in maintaining canalicular membrane stability.
- To understand the link between ATP8B1 deficiency, membrane instability, and cholestasis.
Main Methods:
- Analysis of ATP8B1 gene mutations and protein expression.
- Assessment of canalicular membrane stability in ATP8B1-deficient hepatocytes.
- Investigation of bile salt interactions with the canalicular membrane.
Main Results:
- ATP8B1 deficiency leads to reduced canalicular membrane stability.
- Hepatocytes deficient in ATP8B1 exhibit enhanced extraction of membrane components by bile salts.
- Hypothesized link between cholesterol extraction, impaired bile salt export pump (BSEP) function, and cholestasis.
Conclusions:
- ATP8B1 deficiency causes canalicular membrane instability, contributing to cholestasis in PFIC1.
- Membrane instability may also explain hearing loss observed in some ATP8B1-deficient patients.
- Further research is needed to fully elucidate the etiology of cholestasis and cholestatic episodes.
More Related Videos
Related Concept Videos
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...